Dr. Berim is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
195 Little Albany St
New Brunswick, NJ 08901Phone+1 732-235-8515
Education & Training
University at BuffaloFellowship, Hematology and Medical Oncology, 2009 - 2012- University at BuffaloFellowship, Hematology and Medical Oncology, 2009 - 2011
- University at BuffaloFellowship, Hematology and Medical Oncology, 2009 - 2010
- University at BuffaloResidency, Internal Medicine, 2006 - 2009
Ternopil State Medical UniversityClass of 1999
Certifications & Licensure
NJ State Medical License 2018 - 2025
NE State Medical License 2012 - 2021
NY State Medical License 2009 - 2013- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 140 citationsAdenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell CancerLawrence Fong, Andrew Hotson, John D. Powderly, Mario Sznol, Rebecca S. Heist
Cancer Discovery. 2020-01-01 - 118 citationsMUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer.Surendra K Shukla, Vinee Purohit, Kamiya Mehla, Venugopal Gunda, Nina V Chaika
Cancer Cell. 2017-07-10 - 133 citationsDe Novo Lipid Synthesis Facilitates Gemcitabine Resistance through Endoplasmic Reticulum Stress in Pancreatic Cancer.Saber Tadros, Surendra K. Shukla, Ryan J. King, Venugopal Gunda, Enza Vernucci
Cancer Research. 2017-10-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
